Skip to content

Author

Kai-Ying Lv

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Precision targeting of type 2 inflammation in COPD: identifying candidates for dupilumab therapy

Type 2 (T2) inflammation represents a clinically important and therapeutically tractable endotype in 20%–40% of patients with chronic obstructive pulmonary disease (COPD). This subgroup is characterised by elevated blood eosinophil counts, increased fractional exhaled nitric oxide (FeNO), and activation of the interleu...

Ke-Zhuo Zhong, Kai-Ying Lv, Qun Liang · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.